These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 848924)

  • 1. Microdilution transfer plate technique for determining in vitro synergy of antimicrobial agents.
    Dougherty PF; Yotter DW; Matthews TR
    Antimicrob Agents Chemother; 1977 Feb; 11(2):225-8. PubMed ID: 848924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antibiotic synergism against ocular fungal isolates.
    Stern GA
    Am J Ophthalmol; 1978 Sep; 86(3):359-67. PubMed ID: 309728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of in vitro synergy when amphotericin B is combined with various antimicrobial agents against yeasts by using a colorimetric microdilution checkerboard].
    Yamane N; Behiry IK; Tosaka M; Nakasone I
    Rinsho Byori; 1997 Jul; 45(7):689-95. PubMed ID: 9256018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of terbinafine associated to amphotericin B, fluvastatin, rifampicin, metronidazole and ibuprofen against Pythium insidiosum.
    Cavalheiro AS; Zanette RA; Spader TB; Lovato L; Azevedo MI; Botton S; Alves SH; Santurio JM
    Vet Microbiol; 2009 Jun; 137(3-4):408-11. PubMed ID: 19269752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined effect of amphotericin B and rifampin on Candida species.
    Edwards JE; Morrison J; Henderson DK; Montgomerie JZ
    Antimicrob Agents Chemother; 1980 Mar; 17(3):484-7. PubMed ID: 7425608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined in vitro effect of amphotericin B and rifampin on Cryptococcus neoformans.
    Fujita NK; Edwards JE
    Antimicrob Agents Chemother; 1981 Jan; 19(1):196-8. PubMed ID: 7018384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of oritavancin in combination with rifampin or gentamicin against prosthetic joint infection-associated methicillin-resistant Staphylococcus epidermidis biofilms.
    Yan Q; Karau MJ; Raval YS; Patel R
    Int J Antimicrob Agents; 2018 Nov; 52(5):608-615. PubMed ID: 30048689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro sensitivity of Elavobacterium meningosepticum to antimicrobial agents.
    Altmann G; Bogokovsky B
    J Med Microbiol; 1971 May; 4(2):296-9. PubMed ID: 4105616
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhanced in vitro antimicrobial activity of amphotericin B with berberine against dual-species biofilms of Candida albicans and Staphylococcus aureus.
    Gao S; Zhang S; Zhang S
    J Appl Microbiol; 2021 Apr; 130(4):1154-1172. PubMed ID: 32996236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro activity of commonly used antifungal agents in the presence of rifampin, polymyxin B and norfloxacin against Candida albicans.
    Moneib NA
    J Chemother; 1995 Dec; 7(6):525-9. PubMed ID: 8667037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergy of combinations of vancomycin, gentamicin, and rifampin against methicillin-resistant, coagulase-negative staphylococci.
    Lowy FD; Chang DS; Lash PR
    Antimicrob Agents Chemother; 1983 Jun; 23(6):932-4. PubMed ID: 6555016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
    Oz Y; Akşit F; Kiraz N; Kiremitçi A
    Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of amphotericin B alone or in combination with rifampicin or clarithromycin against Candida species biofilms.
    Del Pozo JL; Francés ML; Hernáez S; Serrera A; Alonso M; Rubio MF
    Int J Artif Organs; 2011 Sep; 34(9):766-70. PubMed ID: 22094555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro effects of Candida albicans of amphotericin B combined with other antibiotics. Preliminary observations.
    Anséhn S; Granström S; Höjer H; Nilsson L; Akesson E; Lundin A; Thore A
    Scand J Infect Dis Suppl; 1976; (9):62-6. PubMed ID: 795012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic interaction in vitro with use of three antibiotics simultaneously against Pseudomonas maltophilia.
    Yu VL; Felegie TP; Yee RB; Pasculle AW; Taylor FH
    J Infect Dis; 1980 Oct; 142(4):602-7. PubMed ID: 7441019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic action of amphotericin B and rifampin against Rhizopus species.
    Christenson JC; Shalit I; Welch DF; Guruswamy A; Marks MI
    Antimicrob Agents Chemother; 1987 Nov; 31(11):1775-8. PubMed ID: 3435124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibilities of sucrose-negative Candida tropicalis, Candida lusitaniae, and Candida norvegensis to amphotericin B, 5-fluorocytosine, miconazole, and ketoconazole.
    Ahearn DG; McGlohn MS
    J Clin Microbiol; 1984 Mar; 19(3):412-6. PubMed ID: 6325491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic action of amphotericin B and rifampin against Candida species.
    Beggs WH; Sarosi GA; Walker MI
    J Infect Dis; 1976 Feb; 133(2):206-9. PubMed ID: 1245767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rifampin Enhances the Activity of Amphotericin B against Fusarium solani Species Complex and Aspergillus flavus Species Complex Isolates from Keratitis Patients.
    He Y; Zhou L; Gao C; Han L; Xu Y
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of amphotericin B alone or in combination with rifampicin on phagocytosis of Candida species by human polymorphonuclear leukocytes.
    Schaumann RF; Shah PM
    Methods Find Exp Clin Pharmacol; 1992 Dec; 14(10):753-8. PubMed ID: 1297891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.